Why this might matter to you
No gene gets more wellness marketing per unit of biology than MTHFR. It's sold as a hidden defect, a reason to buy methylated everything, and the secret behind a long list of unrelated complaints. Its mechanism is actually quite simple - MTHFR is a gene that helps your body turn the folate (vitamin B9) you eat into the active form your cells use. C677T is the most common, ordinary variant in it. You carry zero, one, or two copies, and each copy slows the enzyme down a little. That's a normal piece of human variation, not a diagnosis.
What it does and doesn't change
In people who carry two copies, published studies link the pattern to higher levels of a blood marker called homocysteine, and that link is strongest when folate or B12 intake is low. That's the established, measurable part. What the variant doesn't do is tell you something is wrong with you, or that you need any particular supplement. The effect in the literature is a tendency measured across groups, not a verdict about any single person, and for someone eating an ordinary folate-containing diet it changes far less than the supplement market implies. What follows is the genotype itself, what the studies actually report, and the line between the two.
What the genotype is
MTHFR C677T is read at a single position, rs1801133, on chromosome 1. The reference genotype (G,G) carries no C677T change and shows normal enzyme activity at this position. One copy (G,A) is the heterozygous form. Two copies (A,A) is the homozygous form, often written TT. In Varia's catalog the variant sits in the Methylation and Detoxification module, which covers folate and one-carbon metabolism, the pathway that clears homocysteine and supports methylation reactions throughout the body.
It is a common variant, and the numbers settle the point. In gnomAD reference data the T allele appears at roughly 32 percent globally and roughly 34 percent in the non-Finnish European population, and that dataset records more than 80,000 homozygous individuals. A genotype shared by tens of thousands of catalogued people is variation, not defect.
What the literature reports
The C677T change was first characterized as a common missense mutation that makes the MTHFR enzyme heat-sensitive and lowers its activity, and homozygous individuals showed significantly elevated plasma homocysteine compared with non-homozygous individuals PMID 7647779. Varia's catalog summarizes the activity reduction as roughly 65 percent of normal for one copy and roughly 30 percent of normal for two copies, with mildly elevated homocysteine most relevant when folate or B12 availability is low.
The enzyme converts 5,10-methyleneTHF into 5-methylTHF, the active folate form used to recycle homocysteine back to methionine PMID 20814827. When that step runs slower, homocysteine can accumulate, which is why the literature studies this variant alongside folate and B vitamin status PMID 30693532. The strength of the wider claims drops off from there. A case-control study examining the MTHFR pathway reported an odds ratio of 2.04 for one neural tube defect comparison, but its 95 percent confidence interval ran from 0.9 to 4.7 PMID 9545395. That interval crosses 1.0, which means the data are consistent with no effect at all; the result didn't reach conventional statistical significance. A single study with a wide, boundary-crossing interval is where a finding starts, not where it's settled.
What Varia does with this variant
Varia reads rs1801133 directly from your raw DNA file and resolves your genotype locally on your own device. The result appears under Metabolism and Longevity, in the Methylation and Detoxification module, with the matching catalog summary and the linked, peer-reviewed citations above. We describe what the published evidence reports. We don't tell you what to take or do, and we won't carry a claim the catalog can't cite. Our intention is to hand you the facts as they stand, without sugarcoating and without fear-mongering.
Questions and answers
Is one copy of C677T the same as two?
No. The catalog describes one copy (G,A) as a modest reduction in enzyme activity and two copies (A,A, also called TT) as a larger reduction, with the homozygous form being the configuration most associated with elevated homocysteine in the studies above PMID 7647779.
Does C677T mean something is wrong with my folate?
Not on its own. The variant is common, and its measured effect depends heavily on folate and B vitamin status in the studies that examine it PMID 20814827. It describes a tendency across groups, not a diagnosis for an individual.
Where does Varia get these facts?
Every claim here is drawn from Varia's curated catalog entry for rs1801133 and the peer-reviewed papers it cites. The plain-language summary restates those same sourced facts without adding anything new.
The short version
What is established: C677T is common, two copies lower MTHFR enzyme activity, and homocysteine rises modestly in homozygous individuals when folate or B12 is low PMID 7647779 PMID 20814827.
What is not established: any role for this variant in the broader conditions marketed against it, and any genotype-specific supplement need beyond ordinary folate intake. The one disease-association figure here crossed the line into no-effect territory PMID 9545395.
To check your own genotype and read the cited, peer-reviewed evidence behind it, use the Varia Genome Scanner. It reads your raw DNA file in your browser and checks it for rs1801133 along with the rest of the catalog. Array files like 23andMe and AncestryDNA cover most catalog variants but not all, so the scan tells you whether yours is included, and your file never leaves your device.